RRP5 Antibody

What is the domain structure of RRP5 and how does it relate to function?

RRP5 is a large, highly conserved protein (191 kDa in yeast) with a distinctive multidomain structure comprising 12 S1 RNA binding domains and 7 TPR (tetratricopeptide repeat) motifs. The protein can be functionally divided into two major regions: the N-terminal domain (NTD) containing S1 RNA-binding domains 1-9, and the C-terminal domain (CTD) encompassing S1 domains 10-12 plus all 7 TPR domains .

This domain separation correlates directly with functional specialization. The NTD is specifically required for cleavage at site A3 on the pathway of 5.8S/25S rRNA synthesis, while the CTD is required for cleavages at sites A0-A2 on the 18S rRNA synthesis pathway . When using RRP5 antibodies, it's crucial to know which domain your antibody targets, as this will determine which functional pathway you can effectively study.

How does RRP5 coordinate different pre-rRNA processing pathways?

RRP5 serves as a master coordinator of both small (40S) and large (60S) ribosomal subunit synthesis. UV crosslinking studies have demonstrated that RRP5 binds to specific pre-rRNA regions through its different domains: the CTD crosslinks to sequences flanking the A2 cleavage site, while the NTD crosslinks to sequences flanking the A3 site .

Additionally, RRP5's CTD interacts with snoRNAs required for A0-A2 cleavage (U3, U14, snR30, and snR10), while the NTD interacts with the RNA component of ribonuclease MRP (NME1), which cleaves site A3 . When designing immunoprecipitation experiments using RRP5 antibodies, you should account for these various RNA interactions and consider RNase treatments to distinguish direct protein interactions from RNA-mediated associations.

What protein complexes does RRP5 form during ribosome biogenesis?

RRP5 interacts with numerous proteins during ribosome biogenesis. Mass spectrometry analysis following formaldehyde crosslinking has identified several key protein partners that interact with RRP5 independent of RNA (maintained after RNase treatment):

Most notably, RRP5 associates with large structural proteins containing HEAT or ARM repeats, which are believed to form the physical core of the large terminal balls visualized by electron microscopy in pre-ribosomes . When designing co-immunoprecipitation experiments with RRP5 antibodies, these are key interaction partners to investigate.

How can I distinguish direct RRP5 protein interactions from RNA-mediated associations?

This is a critical methodological question when studying RRP5, which participates in large ribonucleoprotein complexes. To distinguish direct protein interactions from RNA-mediated associations, implement the following protocol:

• Perform parallel immunoprecipitations of your RRP5-tagged protein (e.g., RRP5-HTP) with and without RNase treatment.

• Use stringent purification conditions (e.g., 500mM NaCl) to reduce non-specific interactions.

• For more confidence in detecting direct interactions, consider chemical crosslinking with formaldehyde prior to purification.

• When using mass spectrometry for protein identification, prioritize proteins that maintain at least 30% of their association with RRP5 after RNase treatment .

• Confirm direct interactions through reciprocal immunoprecipitation with GFP-tagged candidate interactors under high salt conditions (500mM NaCl).

The research data indicates that true direct interactors of RRP5 include structural proteins with HEAT/ARM repeats (Utp10, Utp20), NTPases (Kre33), and certain snoRNP components (Nop58) .

What are the best approaches for studying RRP5 binding sites on pre-rRNA?

To effectively map RRP5 binding sites on pre-rRNA, consider implementing the following methodological approach:

• In vivo UV crosslinking and analysis of cDNA (CRAC) to identify direct protein-RNA interactions at nucleotide resolution.

• Analyze both full-length RRP5 and separated domains (NTD and CTD) to map domain-specific interactions.

• Look for point mutations in the cDNA sequences, which indicate direct protein-RNA contacts.

• Compare in vivo crosslinking patterns with in vitro binding assays to distinguish stable from transient interactions.

The research data shows that RRP5's major binding sites are within Internal Transcribed Spacer 1 (ITS1), with the NTD primarily crosslinking 3' to the A3 cleavage site and the CTD crosslinking 3' to the A2 site . When analyzing your crosslinking data, focus particularly on these regions for comparative analysis with published results.

How does RRP5 depletion affect cotranscriptional pre-rRNA processing?

Research utilizing chromatin spreads has demonstrated significant effects of RRP5 depletion on cotranscriptional pre-rRNA processing. When depleting RRP5 in experimental designs:

• Expect complete loss of cotranscriptional cleavage of pre-rRNA.

• Observe dramatically reduced preribosome compaction in chromatin spreads.

• Monitor accumulation of 35S and 23S pre-rRNAs by Northern blotting, indicating delays in cleavage at sites A0-A2.

• Analyze transcription rates, as RRP5 depletion can influence the kinetics of ribosome synthesis.

These observations support the model that RRP5 serves as a critical scaffold protein, coordinating the assembly of preribosomal particles and enabling proper pre-rRNA processing . When designing RRP5 depletion experiments, include these analyses to comprehensively characterize the resulting phenotypes.

What controls should be included when using RRP5 antibodies for immunoprecipitation?

When conducting immunoprecipitation experiments with RRP5 antibodies, implement these critical controls:

• Negative control: Include a strain lacking the tagged version of RRP5 to identify non-specific binding.

• Unrelated protein control: Use antibodies against proteins not expected to interact with RRP5 (e.g., splicing factors like Brr2) to distinguish specific from non-specific interactions .

• RNase control: Perform parallel immunoprecipitations with and without RNase treatment to distinguish direct protein interactions from RNA-mediated associations.

• Salt concentration gradient: Test interactions at different salt concentrations (150mM, 300mM, 500mM NaCl) to assess the stability of different interactions.

• Reciprocal immunoprecipitation: Confirm key interactions by immunoprecipitating the interacting partner and blotting for RRP5.

For protein interaction studies published on RRP5, researchers successfully used formaldehyde crosslinking followed by stringent purification under denaturing conditions (8M urea) to stabilize and identify genuine interactions .

How can I use RRP5 antibodies to study the timing of pre-rRNA cleavage events?

RRP5 antibodies can be powerful tools for studying the temporal dynamics of pre-rRNA processing through the following approach:

• Perform immunoprecipitation of RRP5 (or its separated domains) at different time points after metabolic labeling of RNA.

• Analyze the co-precipitated pre-rRNA species by Northern blotting to determine which species associate with RRP5 at each stage.

• Use domain-specific antibodies to distinguish the roles of the NTD and CTD during processing.

Research has shown that full-length RRP5 completely dissociates from the 20S pre-rRNA region at A2 cleavage, remaining associated only with nascent pre-60S RNAs. After A3 cleavage by RNase MRP, RRP5 is rapidly released from the pre-rRNA . This information can help you interpret the timing of events when analyzing your immunoprecipitation results with RRP5 antibodies.

What technical considerations are important when using RRP5 antibodies for crosslinking studies?

When utilizing RRP5 antibodies in crosslinking studies, consider these technical aspects:

• Crosslinking efficiency: For UV crosslinking of RRP5 to RNA, optimal crosslinking is achieved at 254nm UV light for proteins with aromatic amino acids near RNA binding sites.

• Epitope accessibility: Chemical crosslinking may mask antibody recognition sites; test whether your antibody's epitope remains accessible after crosslinking.

• Stringency of purification: After crosslinking, purification conditions significantly impact which interactions are detected. Formaldehyde crosslinking allows for stringent purification (8M urea, 500mM NaCl).

• Crosslink reversal: For protein-protein interactions, optimize formaldehyde crosslink reversal conditions to efficiently release RRP5 and its partners while maintaining their integrity for downstream analysis.

• Size selection: When analyzing RRP5 crosslinked complexes, focus on the high molecular weight fraction (>191 kDa), as this contains the most relevant multi-protein complexes .

These considerations will help optimize your crosslinking protocols for studying RRP5 complexes.

How should I interpret conflicting data between in vitro and in vivo RRP5 binding patterns?

When confronted with differences between in vitro and in vivo RRP5 binding patterns:

• Recognize that the combined binding sites from the separated NTD and CTD domains more closely resemble the in vitro pattern for the full-length protein than the in vivo pattern .

• Consider that growth rates affect binding patterns - strains with separated RRP5 domains show slower growth and pre-rRNA processing, potentially allowing detection of normally transient interactions.

• Analyze the accumulation of 35S and 23S pre-rRNAs by Northern blotting, as these indicate delays in processing that may explain binding pattern differences.

• Compare point mutations in cDNA sequences between in vivo and in vitro experiments, as these indicate direct protein-RNA contacts.

The research shows that reduced growth supported by separated domains of RRP5 correlates with delays in cleavage at sites A0-A2 and accumulation of preribosomal particles, which may explain certain discrepancies in binding patterns .

What does the absence of RRP5 in purified intermediates indicate about its role in ribosome assembly?

The absence of RRP5 in later pre-ribosomal intermediates provides important insights:

• RRP5 dissociates completely from the 20S pre-rRNA after A2 cleavage, indicating its role is primarily in early assembly steps.

• RRP5 remains briefly associated with 27SA2 pre-rRNA until A3 cleavage, then rapidly dissociates.

• The coordinated release of RRP5 from multiple binding sites after specific cleavage events suggests an active recycling mechanism.

• RRP5 likely functions as a molecular scaffold that helps establish the correct architecture for cleavage events but is not needed for subsequent maturation steps.

These observations indicate that RRP5 serves as a transient assembly factor rather than a core component of mature pre-ribosomes . When analyzing purified pre-ribosomal intermediates, the presence or absence of RRP5 can help determine the precise stage of maturation.

How can I determine if my RRP5 antibody is detecting the functional pool of the protein?

To ensure your RRP5 antibody is detecting the functionally relevant population:

• Perform cellular fractionation to separate nucleolar, nucleoplasmic, and cytoplasmic compartments, then blot for RRP5 - functional RRP5 should be predominantly nucleolar.

• Use glycerol gradient fractionation to separate different-sized complexes and determine if your antibody detects RRP5 in the high molecular weight fractions containing pre-ribosomes.

• Analyze co-immunoprecipitation of known RRP5 interactors (e.g., Utp10, Utp20, Kre33) and pre-rRNA species.

• Compare binding patterns with published crosslinking data showing RRP5 binding to specific pre-rRNA regions like ITS1.

Based on the research data, functional RRP5 should interact with large structural proteins containing HEAT/ARM repeats and various snoRNAs required for pre-rRNA processing . Absence of these interactions may indicate your antibody is detecting a non-functional pool of the protein.

How can I design experiments to study the role of RRP5 in coordinating distant pre-rRNA processing events?

RRP5 has been implicated in linking processing events at distant sites in the pre-rRNA. To investigate this coordination function:

• Create domain-specific deletions or mutations in RRP5 and analyze effects on processing at various sites.

• Perform crosslinking studies with mutant forms of RRP5 to identify changes in binding patterns.

• Investigate the timing of A3 cleavage in strains with mutations in the 3' ETS, as RRP5 may link events in the 3' ETS to A3 cleavage .

• Design reporter constructs with inserted sequences between distant processing sites to test if RRP5 can still coordinate processing.

• Use high-resolution microscopy to visualize the spatial organization of processing events in cells with wild-type versus mutant RRP5.

The available research suggests that RRP5 is a plausible candidate to link processes at distant sites, such as events in the 3' ETS with A3 cleavage . Your experimental design should test this coordination model.

What approaches can determine the structural role of RRP5 in preribosome compaction?

To investigate RRP5's structural role in preribosome assembly:

• Combine RRP5 immunoprecipitation with electron microscopy to visualize RRP5-containing particles.

• Use chromatin spreads to compare preribosome compaction in wild-type, RRP5-depleted, and domain-specific mutants.

• Perform crosslinking mass spectrometry (XL-MS) to map the physical interactions between RRP5 and large structural proteins with HEAT/ARM repeats.

• Create mutations in the TPR domains of RRP5 and analyze effects on protein interactions and preribosome compaction.

• Implement Cryo-EM to determine structural changes in preribosomes upon RRP5 depletion or mutation.

Research indicates that RRP5, together with large HEAT/ARM repeat proteins (Utp20, Utp10, Mak21/Noc1, Noc2, and Rix1), likely forms the physical core of the large terminal balls visualized in electron microscopy . This structural role is crucial for understanding how RRP5 coordinates pre-rRNA processing.